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Abstract 
Master Thesis, Programme in Medicine  
Treatment, rehabilitation and awareness of stroke in a region with limited resources – A 
descriptive study in the West Bank, the occupied Palestinian territory 
Johan Hultegård, 2014  
Department of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 
Sweden 
 
Background 
Stroke is the second most common global cause of death. Screening, post-stroke 
rehabilitation, secondary prevention, an increased knowledge of stroke symptoms and risk 
factors could decrease the mortality of stroke.      
Aim 
The purpose was to describe the general conditions in cerebrovascular health care at Palestine 
Medical Complex (PMC) and further to investigate the awareness of risk factors and 
symptoms in stroke among non-stroke patients at PMC. 
Methods 
Twenty-nine patients with diagnosed stroke were included and examined during eight weeks 
at PMC for an observational study. Ninety-two non-stroke patients were included at a general 
ward, PMC, for a questionnaire study.  
Results 
Twenty-five percent of ischemic stroke patients were prescribed the combination 
acetylsalicylic acid + Plavix®. Furosemid® (39%) were most common treatment of 
hypertension. Patients with NIHSS 3-14 (National Institutes of Health stroke scale) and 
patients under 65 years were more frequently receiving rehabilitation and follow-up than 
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patients with NIHSS >15 and elderly patients.  
Seventy-five percent of the non-stroke patients recognized ≥1 correct symptom. Patients with 
university studies were more likely to recognize >2 correct risk factors (OR 9.6, 95% CI 1.9-
49.5, P=0.007). Patients in 40-59 years and in ≥60 years were more likely to recognize ≥1 
correct symptoms (OR 4.1, 95% CI 1.4-12.2, P=0.011 respectively OR 8.8, 95% CI 1.7-44.3, 
P=0.009). 
Conclusion 
Patients with severe stroke and high age were less frequently receiving rehabilitation and 
follow-up in our stroke population. Some generally unproven treatment combinations were 
common among stroke patients. Future studies is needed which could possibly contribute to 
guidelines for treatment and rehabilitation at PMC.    
The awareness study showed a lack of general knowledge concerning stroke symptoms. 
University studies and high age were associated with increased recognition of stroke 
symptoms and risk factors. A study representative for the whole population is suggested to 
address the areas for public information. 
 
 
 
 
 
 
 
 
 
 
6 
 
Background 
The second most common global cause of death is cerebrovascular disease, causing 5.9 
million deaths/year, and an incidence of 258 persons per 100 000 persons [1]. Usually 
cerebrovascular diagnoses are divided into two main types: ischemic stroke and hemorrhagic 
stroke, although the wide classification of cerebrovascular disease is also including transient 
ischemic attack, asymptomatic carotid stenosis, sinus thrombosis [2]. Stroke is a symptom-
based diagnosis – WHO:s stroke definition is “rapidly developed clinical signs of focal (or 
global) disturbance of cerebral function, lasting more than 24 hours or leading to death, with 
no apparent cause other than of vascular origin" [3]. Cerebrovascular disease has been 
considered as the disease of the ageing population, but there are indications of a growing 
trend in incidence among younger people. Rosengren et al highlighted this trend in a recent 
publication – an increasing incidence of ischemic stroke during 1987-2010 among persons 
under the age of 65 years [4]. Disability-adjusted life years (DALYs) is an instrument used to 
measure disease burden; the life years lost caused by death are added to the life years with 
disability. Cerebrovascular disease has the third highest number of DALYs globally, with 
ischemic heart disease in first and lower respiratory disease in second [5]. Feigin et al have 
estimated the global and regional burden of stroke and found a decreasing trend in stroke 
mortality during the last twenty years. In contrary they also showed that the absolute number 
of affected people, stroke survivors and DALYs lost are increasing, especially in low- and 
middle-income countries [1].  
 
The risk for developing stroke is multifactorial – e.g. transient ischemic attack, high blood 
pressure, diabetes mellitus, smoking, psychological stress, high body mass index, atrial 
fibrillation are independent long-term risk factors for developing stroke [6]. A study by Ezzati 
et al indicates that a few risk factors are together attributable to 70–76% of stroke disease 
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burden, with hypertension as the main risk factor [7]. The comprehensive INTERSTROKE 
study identified ten risk factors correlative to 90% of all stroke types (hypertension, current 
smoking, waist-to-hip ratio, diet risk score, physical inactivity, diabetes mellitus, alcohol 
intake, psychosocial stress and depression, cardiac causes, ratio of apolipoprotein B to A1). 
The authors suggest interventions to reduce the burden of stroke – e.g. hypertension treatment 
and smoking reduction, physical activity and healthy diet promotion [8]. As mentioned above 
hypertension is the most important risk factor, and in a meta-analysis Law et al showed that a 
reduction of 10 mmHg systolic and 5 mmHg diastolic blood pressure correlated with 41% 
reduction in stroke accidents [9].  
 
Another aspect of reducing the burden of stroke and improving survival in stroke is the time 
from onset of symptoms to acute in-hospital treatment e.g. tissue plasminogen activator (tPa).  
TPa is used as a thrombolytic treatment in ischemic stroke patients. To decrease mortality and 
sequel symptoms tPa has to be administered to the patient before 4.5 hours from symptom 
onset. Therefore, it is of great importance to decrease the delay in time from symptom onset 
to in-hospital treatment. The delay in time could be divided into two components: pre-hospital 
delay factors and in-hospital delay factors. The pre-hospital factors are more patient-related – 
the care-seeking behaviour from the first appearance of neurological symptoms to emergency 
room arrival [2, 10]. Faiz et al showed in a Norwegian study that more than half of the stroke 
patients pre-hospital delay time was caused by decision delay i.e. time from onset of 
symptoms to first medical contact. Increasing the stroke awareness and knowledge among 
high risk individuals have been suggested to reduce the pre-hospital delay [11]. 
 
The risk for developing a stroke is high the first 3 months after a minor stroke or TIA, nearly 
20% according to Coull et al. Even the first 7 days after minor stroke/TIA is critical with an 
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estimated risk for a stroke of 8% in TIA patients respectively 12% in minor stroke patients. 
These analysis have raised the question regarding possibilities to reduce the incidence in early 
recurrent stroke with rapid secondary preventive treatment [12]. Rothwell et al showed in 
their prospective study that the risk for recurrent stroke the first 3 months after a stroke 
incident could be reduced by 80% with rapid assessment and preventive treatment [13]. Early 
rehabilitation is a cornerstone of stroke treatment guidelines around the world and a lot of 
research studies has been investigating the effect of rehabilitation. Cumming et al conducted a 
RCT – one group receiving very early rehabilitation (within 24 hours from stroke onset) and 
another group receiving standard stroke rehabilitation. The outcomes in the very early 
rehabilitation group were sooner recovery in terms of less days from symptom onset to 
walking a 50 m distance unassisted and also a higher rate of patients discharged to home 
instead of rehabilitation centre [14].       
 
Health care in the occupied Palestinian territory 
The occupied Palestinian territory (oPt) has a population of 4.2 million citizens and 75 000 
are situated in Ramallah, the administrative capital of the West Bank [15]. The Israel-Palestine 
area is strongly associated with conflict and the people living in the area has suffered and are 
suffering from consequences of the unsolved political situation. One consequence of the 
conflict is inadequate health care. The access to hospitals and other health care institutions are 
restricted by the Israeli authorities – e.g. patients in need for specialized care in East 
Jerusalem, Israel. Restrictions of movement are supported by military orders and different 
regulations. The patients need a valid permit to enter the area of East Jerusalem and especially 
elderly patients and children are extra vulnerable. Another aspect of the conflict is restricted 
drug storage and lack of general resources [16]. Decreased access to medicine together with a 
high rate of unemployment [15] are obstacles for chronic treatments e.g. secondary stroke 
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prevention and hypertensive medication. In the oPt there is a lack of research on 
cerebrovascular disease, Sweileh et al has conducted studies on both stroke epidemiology and 
discharge medications in the Nablus district, northern oPt. They found that hypertension 
(70%), diabetes mellitus (45%), renal dysfunction (34%) and smoking (21%) were common 
risk factors in their patient material. On discharge day, every stroke patient was prescribed, in 
average 4.9 drugs (SD =1.9), including antiplatelet treatment and other medications. An 
average monthly income in Palestine is less than 200 USD. This highlights the economic 
burden for the relatives of stroke patients and the problem with secondary prevention for the 
Palestinians [17, 18]. 
 
Screening, better control of risk factors, post-stroke rehabilitation and secondary prevention 
are suggested to decrease the mortality of stroke disease. An increased awareness and 
knowledge of risk factors and cerebrovascular disease may lead to a better cerebrovascular 
health care – decreasing the time from onset of symptoms to hospital arrival and diminishing 
the impact of risk factors. My research question is therefore twofold: 
 
How is the medical care of patients with stroke at Palestine Medical Complex performed, 
concerning defining diagnosis, post-stroke treatment and rehabilitation? 
 
What is the general knowledge regarding risk factors and symptoms in cerebrovascular 
disease among non-stroke patients at Palestine Medical Complex?  
 
 
Aim 
The purpose of this study is to describe the general conditions in cerebrovascular health care 
at Palestine Medical Complex and further to investigate the awareness of risk factors and 
symptoms in stroke amongst non-stroke patients at Palestine Medical Complex. Earlier 
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awareness studies have shown a correlation between increased awareness and higher 
education level, history of smoking, history of cardiac disease, family history of stroke, 
younger age [19-22].  
 
 
Material and methods 
To answer the research questions the project was divided into an observation study and a 
questionnaire, both performed March-April 2014 at Palestine Medical Complex (PMC), 
Ramallah.  
 
Sample 
The study population for the observation study were consecutive selected patients diagnosed 
with stroke (n=29) during eight weeks, 4 days/week 9 a.m. to 3 p.m. at PMC. The stroke 
diagnoses were confirmed by CT scan and after assessment of neurologist, Dr Zaid Ghanim. 
The aim for this study was to include every stroke patient passing by the Emergency room 
(ER), approximately 30-60 patients. An unknown number of stroke patients were discharged 
from the ER without assessment of neurologist and therefore it was not possible to include 
them in the material. Beside that exclusion, 3 patients were excluded due to already 
participated in the study, discharged by the medical staff before our assessment or went home 
against advice.      
 
To define the study sample for the questionnaire a general ward with non-stroke patients were 
chosen. The ward consisted of patients from varied specialities – surgery, orthopaedics and 
medicine. The questionnaire was distributed to non-stroke patients (n=92) at the ward during 
eight weeks, once per week. All in-ward patients, at the specific time for distribution of the 
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questionnaire, were included except 41 patients due to previous diagnosed stroke, age ≤ 15 
years, anxiety, decreased level of consciousness, not willing to participate and infectious 
isolation.      
 
Data collection procedures 
For examination of the patients a protocol (see appendices) was used. Data concerning time to 
hospital, age, gender, heredity of cerebrovascular accidents (CVA), previous transient 
ischemic attack (TIA)/stroke, previous coronary artery disease, atrial fibrillation, smoking, 
diabetes, hypertension, hyperlipidaemia, current treatment was collected through the 
patients/relatives or reading case books. To measure body mass index (BMI) the 
patients/relatives were asked about approximate length and weight. The variables BMI and 
heredity of CVA were lost in 1 patient due to early discharge from the ward. National 
Institutes of Health Stroke Scale, NIHSS, was used to examine the patients and for additional 
assessment of neurological deficits we also examined: hearing test using finger snapping, 
Rombergs test, uvula deviation, pupillary reaction using flashlight, diadochokinesia tests, 
Babinskis test, reflexes in biceps, brachioradialis, patella and achilles. For blood pressure 
measurement we used case book notes (selecting the first noted value the first and second 
day). The staff used following devices for measurement of blood pressure: Criticare 
Comfortcuff 506N3, Criticare nGenuity 8100E, Criticare nCompass 8100H or Welchallyn 
Masimo Set 53STO.  
Lab tests (venous P-glucose) were collected from case books (selecting the first P-
glucose after admission to ER). The blood pressure (n=2) and the P-glucose (n=3) were 
sometimes not found in the case books. Lipid blood samples were not part of standard routine 
at the hospital and not investigated. The conversations with patients/relatives were interpreted 
by Dr Ghanim or Palestinian medical students. During the physical examination the 
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abovementioned tests were performed by medical student Johan Hultegard or Dr Ghanim. The 
diagnosis and the location of lesion were confirmed by Dr Ghanim using CT scan together 
with clinical picture. Oxfordshire Community stroke project (OCSP) classification [23] was 
applied for subgrouping the stroke diagnoses. Data concerning treatment, active treatment 
start, rehabilitation, follow-up, discharge day were collected verbally from Dr Ghanim or case 
books. Data concerning active treatment start was missing in 1 patient due to unmodified 
medication. Data concerning rehabilitation, follow-up and discharge day were missing in 1 
patient due to death during hospital stay. Rehabilitation and follow-up plan were unknown in 
3 patients due to referrals to hospitals located in Israel.            
  
The structure of the questionnaire (see appendices) was previous used in a similar study 
performed in Korea [19]. The first part was divided into close-ended questions: age, gender, 
education and smoking. The second part contained two questions about knowledge in stroke 
risk factors and stroke symptoms. The patients were asked to name 4 or less risk factors 
respectively 4 or less stroke symptoms. The risk factors and stroke symptoms were evaluated 
and divided into correct responses and incorrect responses. The English version was translated 
to Arabic by Dr Ghanim and the patients answered the questions verbally or in written form. 
The answers were translated by Dr Ghanim or Palestinian medical students. Before 
participating in the study the patients were asked if they had medical history of stroke or if 
they already had participated in this study, thus avoiding to include stroke patients in the non-
stroke material and double registration of patients. 
 
Statistical methods 
IBM SPSS Statistics version 22 was used to calculate number, percentage, mean, median and 
range. The diagrams were structured in Microsoft Excel 2013 and IBM SPSS statistics 
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version 22. Mann-Whitney U-test was used to investigate differences between gender and age 
groups concerning time from onset of symptoms to arrival to Emergency Room. To compare 
the mean values of correct recognized risk factors and correct recognized symptoms in 
different age groups ANOVA test was performed. Binary logistic regression analysis was used 
to investigate associations between the indicators age, gender, education level, smoking level 
and the variables knowledge of >2 risk factors and knowledge of ≥1 symptom. Statistical 
significance was set at p≤0.05. 
 
 
Ethics 
Ethic approval for the research study was given from the direction of Palestine Medical 
Complex. The patients were verbally informed regarding the study, voluntary participated and 
registered anonymous regarding data before participating in the study. Verbal informed 
consent was collected from the patients or their relatives. All protocols and questionnaires 
were structured with individual numbers and the Palestinian ID-numbers were removed when 
the material left the hospital. This study was not considered as harmful for the patients and 
had a low-risk for intervening the medical stroke care. 
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Results 
Observation study 
In the observation study data was collected from 29 stroke patients passing by the ER at PMC. 
Table 1 shows the age and sex distribution in the study material. The mean age among men 
was 6.6 years lower than the mean age among women. Half of the patients were 60-79 years, 
nearly a fifth were over 80 years and a third of the cases were under 60 years. The patients 
were almost equivalent distributed in gender.    
 
Table 1. Demographic data of stroke patients (n=29). Data 
presented in mean (SD) or numbers (%). 
 
Age 65.1 (14.6) 
          Women 68.5 (15.2) 
          Men 61.9 (13.9) 
          <50 years  3 (10%) 
          50-59 years 7 (24%) 
          60-69 years 8 (28%) 
          70-79 years 6 (21%) 
          >80 years 5 (17%) 
Sex  
          Women 14 (48%) 
          Men 15 (52%) 
 
 
The most common stroke diagnosis was ischemic stroke and just over an eighth of the patients 
had hemorrhagic stroke (Table 2). After admission to the ER every patient underwent a CT 
scan. We examined the patients on average 2.5 (SD 1.2) days after symptom debut and during 
that specific examination the median value of NIHSS were 8.0 (IQR 2.0-14.5). 
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Table 2. Clinical characteristics of stroke patients (n=29). Data 
presented in numbers (%), mean (SD) or median (IQR). 
 
Diagnosis (n=29)  
          Ischemic stroke 24 (83%) 
          Transient ischemic attack 1 (3%) 
          Hemorrhagic stroke 4 (14%) 
OCSP classification of ischemic strokes (n=24)  
          Total anterior circulation infarction 5 (21%) 
          Partial anterior circulation infarction 6 (25%) 
          Posterior circulation infarction 5 (21%) 
          Lacunar infarction 8 (33%) 
TIA (n=1) 1 (100%) 
Classification of haemorrhagic strokes (n=4)  
         Lacunar hematoma 2 (50%) 
         Subarachnoid haemorrhage 1 (25%) 
         Posterior circulation hematoma 1 (25%) 
Diagnostics (n=29)  
         CT scan 29 (100%) 
Severity of stroke (n=29)   
         NIHSS 8.0 (2.0-14.5) 
         Assessment of NIHSS, x days after symptom onset 2.5 (1.2) 
OCSP= Oxfordshire Community stroke project, TIA= transient ischemic attack, CT= computed tomography, NIHSS= National Institutes of 
Health stroke scale, SD= standard deviation, IQR= interquartile range.  
 
 
 
 
In our patient material the most common risk factors (Table 3 and Fig. 1) were overweight 
(64%), hypertension (62%), diabetes mellitus (48%) and smoking (35%). Hyperlipidemia, 
coronary artery disease and atrial fibrillation were more prominent among the male patients, 
67% of the men were either smokers or ex-smokers, compared to none of the women who 
identified themselves as smokers or ex-smokers.  
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Table 3. Distribution of risk factors in stroke patients (n=29). Presented in numbers (%). 
 Female Male Total 
Atrial fibrillation (n=29) 1 (7%) 3 (20%) 4 (14%) 
Diabetes mellitus (n=29) 7 (50%) 7 (47%) 14 (48%) 
Heredity CVA (n=28) 3 (23%) 6 (40%) 9 (32%) 
Hyperlipidaemia (n=29) 3 (21%) 5 (33%) 8 (28%) 
Hypertension (n=29) 9 (64%) 9 (60%) 18 (62%) 
Overweight BMI (n=28) 10 (71%) 8 (53%) 18 (64%) 
         Overweight BMI 25.0 – 29.9 2 (14%) 6 (40%) 8 (29%) 
         Obesity BMI ≥30.0 8 (57%) 2 (13%) 10 (36%) 
Previous CAD (n=29) 2 (14%) 5 (33%) 7 (24%) 
Previous CVA (n=29) 4 (29%) 3 (20%) 7 (24%) 
Smoking (n=29) 0 (0%) 10 (67%) 10 (35%) 
         Ex-smoker 0 (0%) 4 (27%) 4 (14%) 
         Smoker 0 (0%) 6 (40%) 6 (21%) 
CVA= cerebrovascular accidents, BMI= body mass index, CAD= coronary artery disease. 
 
Among the female stroke patients 71% had a BMI above 25.0, compared to 53% of the male 
patients. The gender difference was even larger in the patient group with BMI above 30.0 
(57% to 13%).        
 
 
 
 
 
 
 
 
 
Figure 1. Distribution of risk factors in stroke patients (n=29). Presented in %. Obesity category includes 
overweight (BMI 25.0-29-9) and obesity (BMI ≥30.0). Smoking category includes ex-smokers and smokers. 
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Concerning the time from onset of symptoms to arrival at ER, (Table 4) our patient material 
had a great range, from 0.5 h to 48 h. The median time was lower for the male patients. There 
was also a difference between women in ages ≤65 years and >65 years. When analyzing men 
and women together the median time was 1.0 h, in both age groups. The patients were 
discharged on average 3.6 days after symptom debut (Table 5).   
 
Table 4. Time from onset of symptoms to arrival Emergency Room. Presented in hours (SD). 
 Women Men Total 
 Mean Median Mean Median Mean Median 
Time to hospital (n=29) 8.6 (13.7) 3.0 3.7 (6.7) 1.0 6.1 (10.9) 1.0  
   Age ≤65 years (n=15) 7.3 (11.3) 2.3 4.8 (8.0) 1.0 5.5 (8.7) 1.0  
   Age >65 years (n=14) 9.2 (15.2) 3.0 1.1 (0.9) 0.8  6.7 (13.0) 1.0 
 
 
Table 5. Active treatment start and discharge day. Presented in number of days after 
symptom onset. Mean (SD) and median (IQR).  
 Mean Median 
Active treatment start after onset (n=28) 2.1 (1.2) 2.0 (1.3-2.8) 
Discharge day after onset (n=28) 3.6 (2.4) 3.0 (2.0-4.8) 
 
 
In Fig. 2 antiplatelet and anticoagulant treatment among TIA/ischemic stroke patients were 
compared before the stroke accident and after the stroke accident. Six patients (24%) were 
prescribed the treatment combination acetylsalicylic acid + Plavix® as secondary prevention. 
Over 50 % of the stroke patients were prescribed Clexane® for one week. Two patients (8%) 
were discharged without any secondary prevention. Tissue Plasminogen activator (tPa) was 
not available at PMC. 
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Figure 2. Antiplatelet and anticoagulant treatment in ischemic stroke and TIA patients (n=25). Presented in 
numbers and divided into pre-stroke and post-stroke treatment. ASA= acetylsalicylic acid. 
 
 
 
Eighty-nine percent of the stroke patients with already diagnosed hypertension had an 
antihypertensive treatment. In Fig. 3 the distribution of antihypertensive treatment among the 
stroke patients with hypertension is presented. Furosemid® (39%), enalapril (28%) and 
atenolol/bisoprolol (22%) were the most frequent medications.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Antihypertensive pre-stroke treatment in stroke patients with diagnosed hypertension (n=18). Presented 
in numbers. The columns including both single and combination therapies. 
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Figure 4 shows that 19 (70%) of the stroke patients had a mean high blood pressure (mean 
systolic BP ≥140 mmHg and/or mean diastolic BP ≥90mmHg), 7 patients (26%) with a mean 
high blood pressure had no history of hypertension.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Mean systolic blood pressure ≥140 mmHg and/or mean diastolic blood pressure ≥90 mmHg among the 
stroke patients (n=27) based on two different measurements. Presented in numbers. 
 
Figure 5 describes the most common antidiabetic treatment in the study population – 
metformin, glibenklamid and insulin. When measuring non-fasting venous plasma-glucose 
(Fig. 6) 7 of 11 (63%) diabetic stroke patients had a venous P-glucose ≥11.1 mmol/l, 2 
patients without previous diabetes diagnosis had also a venous P-glucose ≥11.1 mmol/l. No 
significant differences between men and women were found concerning vP-glucose values.  
 
 
 
 
 
 
 
 
 
Figure 5. Anti-diabetic treatment among the stroke patients with diagnosed diabetes (n=14). Presented in 
numbers. 
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Figure 6. Non-fasting vP-glucose measurement in mg/dl and mmol/l in stroke patients (n=26). Presented in 
numbers. 
 
 
The patients with hemorrhagic stroke (n=4) were prescribed two different medications – 4 
patients got dexamethasone for several days and 2 patients got additional treatment with 
mannitol.  Concerning rehabilitation (Fig. 7-8), 9 (32%) patients were discharged with either 
rehabilitation at home or at physiotherapy clinic. The elderly individuals were more 
frequently receiving rehabilitation at home than the patients ≤65 years, 16 (57%) patients 
were discharged from the ward without any rehabilitation. When analysing the rehabilitation 
regarding NIHSS-score the patients with more severe stroke (NIHSS >15) and the patients 
with minor symptoms (NIHSS <2) were prescribed less rehabilitation.  
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Figure 7. Post-hospitalization rehabilitation in stroke patients, related to age (n=28). Presented in numbers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Post-hospitalization rehabilitation in stroke patients, related to NIHSS (n=28). Presented in numbers. 
22 
 
0
2
4
6
8
10
12
No follow-up Neurological
clinic
Nefrological
clinic
TTE + carotis
doppler
Thrombophili
investigation
MRI, MRA and
MRV
Unknown
N
u
m
b
er
≤65 years n=14 >65 years n=14
Figure 9 shows the distribution of different follow-ups. Nine (32%) patients were discharged 
without any follow-up, most of them were elderly patients, 15 (54%) patients were planned a 
visit in 2-3 months at neurological out-patient clinic. Some of the patients were also 
investigated with TTE, carotid Doppler, thrombophilia investigation, MRI, MRA and MRV. 
No significant differences between men and women were found concerning rehabilitation and 
follow-up. 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Follow-up in stroke patients, related to age (n=28). Presented in numbers.  
TTE= transthoracic echocardiogram, MRI= magnetic resonance imaging, MRA= magnetic resonance 
angiography, MRV= magnetic resonance venography.  
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Questionnaire study 
The questionnaire was distributed to 92 non-stroke patients (41% women, 59% men). The 
mean age of the study population was 47 years. Among the participants 16% had no 
education, 32% went to primary school, 34% went to secondary school and 19% had studied 
at university level. Half of the patients were non-smokers and the other half were ex-smokers 
or current smokers.  
Table 7. Characteristics of non-stroke questionnaire patients (n=92). Presented in 
mean (SD) or numbers (%). 
Age 46.9 (16.9) 
          Women 53.1 (15.0) 
          Men 42.6 (16.9) 
          15-39 years 30 (33%) 
          40-59 years 40 (43%) 
          ≥60 years 22 (24%) 
Sex  
          Women 38 (41%) 
          Men 54 (59%) 
Education level  
         No education 15 (16%) 
         Primary school 29 (32%) 
         Secondary school 31 (34%) 
         University 17 (18%) 
Smoking  
         Never-smoker 48 (52%) 
         Ex-smoker 23 (25%) 
         Smoker 21 (23%) 
 
In Table 8 most common recognized risk factors and symptoms are listed, related to age 
groups. Stress (69%), hypertension (36%), smoking (34%) and hyperlipidaemia (27%) were 
the most frequently answers in our study population. The mean correct answered risk factors 
were 2.3 and when analysing the patients related to age groups there was a difference from 
2.0 (15-39 years) to 2.5 correct answers (≥60 years). This difference were not significant 
(P=0.232), 96% of the non-stroke patients were aware of at least one risk factor. 
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Table 8. Knowledge of risk factors (n=92). Presented in numbers (%) and mean (SD). 
 Total Age 
  15-39 years 40-59 years  ≥60 years 
Risk factors     
          Stress* 63 (69%) 16 (53%) 31 (78%) 16 (73%) 
          Hypertension* 33 (36%) 9 (30%) 15 (38%) 9 (41%) 
          Smoking* 31 (34%) 11 (37%) 13 (33%) 7 (32%) 
          Hyperlipidaemia* 25 (27%) 7 (23%) 10 (25%) 8 (36%) 
          Diabetes mellitus* 12 (13%) 2 (7%) 5 (13%) 5 (23%) 
          Dietary fat intake* 11 (12%) 3 (10%) 3 (8%) 5 (23%) 
          Depression or anxiety* 7 (8%) 1 (3%) 5 (13%) 1 (5%) 
          Obesity* 7 (8%) 2 (7%) 3 (8%) 2 (9%) 
          Cardiac causes* 6 (7%) 1 (3%) 5 (13%) 0 (0%) 
          Food intake (spicy, fried, artificial) 6 (7%) 3 (10%) 2 (5%) 1 (5%) 
          Physical inactivity* 5 (5%) 3 (10%) 2 (5%) 0 (0%) 
Mean correct response 2.3 (1.1) 2.0 (1.2) 2.4 (1.0) 2.5 (0.9) 
Knowledge of  ≥ 1 risk factor 88 (96%) 26 (87%) 40 (100%) 22 (100%) 
*considered as correct recognized risk factor. 
 
Headache (21%), weakness in arms and legs (20%), loss of consciousness (19%), vertigo 
(17%) were most common recognized stroke symptoms (Table 9). The patients recognized in 
average 1.4 correct symptoms and, in similarity with the knowledge of risk factors, the elderly 
patients had a higher mean correct symptom response. This difference when comparing age 
groups were not significant (P=0.086), 75% of the study population recognized ≥1 correct 
symptom and among patients 15-39 years 53% recognized ≥1 correct symptom.      
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Table 9. Knowledge of symptoms in stroke (n=92). Presented in numbers (%) and mean (SD). 
 Total Age   
  15-39 years 40-59 years  ≥60 years 
Symptoms     
          Headache* 19 (21%) 6 (20%) 6 (15%) 7 (32%) 
          Weakness in arms and legs 18 (20%) 4 (13%) 7 (18%) 7 (32%) 
          Loss of consciousness* 17 (18%) 5 (17%) 9 (23%) 3 (14%) 
          Vertigo* 16 (17%) 4 (13%) 7 (18%) 5 (23%) 
          Hemiparesis* 13 (14%) 2 (7%) 8 (20%) 3 (14%) 
          Mouth or tongue deviation* 12 (13%) 5 (17%) 4 (10%) 3 (14%) 
          Sweating 11 (12%) 1 (3%) 7 (18%) 3 (14%) 
          Dyspnoea 10 (11%) 3 (10%) 6 (15%) 1 (5%) 
          General fatigue 10 (11%) 2 (7%) 6 (15%) 2 (9%) 
          Sensory loss* 9 (10%) 3 (10%) 2 (5%) 4 (18%) 
          Aphasia* 8 (9%) 1 (3%) 4 (10%) 3 (14%) 
          Dysarthria* 8 (9%) 1 (3%) 3 (8%) 4 (18%) 
          Pain 8 (9%) 2 (7%) 4 (10%) 2 (9%) 
          Peripheral cyanosis 8 (9%) 3 (10%) 3 (8%) 2 (9%) 
          Amnesia* 6 (7%) 2 (7%) 3 (8%) 1 (5%) 
          Nausea* 5 (5%) 0 (0%) 4 (10%) 1 (5%) 
          Confusion 5 (5%) 0 (0%) 4 (10%) 1 (5%) 
          Visual loss* 5 (5%) 1 (3%) 2 (5%) 2 (9%) 
Mean correct response           1.4 (1.1) 1.0 (1.2) 1.4 (0.9) 1.7 (1.0) 
Knowledge of  ≥ 1 symptom 69 (75%) 16 (53%) 33 (83%) 20 (91%) 
*considered as correct recognized symptom. 
 
We found significant correlations between university studies, age and increased knowledge of 
risk factors/symptoms. Patients with university studies were more likely to recognize >2 
correct risk factors (OR 9.6, 95% CI 1.9-49.5, P=0.007) compared with the patients without 
any education. Patients in ages 40-59 years and ages ≥60 years were more likely to recognize 
≥1 correct symptoms (OR 4.1, 95% CI 1.4-12.2, P=0.011 respectively OR 8.8, 95% CI 1.7-
44.3, P=0.009), when compared with the patients in ages 15-39 years. No significant 
correlations were found between smoking level, sex and increased awareness. 
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Discussion 
In the group of ischemic stroke/TIA patients we found an unexpected distribution of 
antiplatelet and anticoagulant treatment: twenty-five percent were prescribed antiplatelet 
treatment combination acetylsalicylic acid (ASA) + Plavix® and over 50% were prescribed 
Clexane® for one week. Among the stroke patients Furosemid® (39%) were most common 
hypertensive treatment. Rehabilitation and follow-up were more frequently prescribed to 
patients under 65 years than to elderly patients. The patients with moderate stroke (NIHSS-
score 3-14) were more frequently prescribed rehabilitation than the patients with severe stroke 
(NIHSS-score >15).  
In the awareness study 75% of the non-stroke participants could recognize ≥1 
symptoms and in the age 15-39 years the results were even lower (53%). We found a 
correlation between high age, education level and knowledge of symptoms/risk factors. 
Patients with university studies were more likely to know >2 risk factors and patients in age 
above 40 years were more likely to know ≥1 symptom. These are the main findings in our 
study. 
 
Tissue plasminogen activator was not available at PMC, instead the secondary preventive 
combination ASA + Plavix® were common (25% of the ischemic stroke/TIA patients) in the 
study population. Usually the patients in this study were added Plavix® to an already existing 
ASA treatment as secondary prophylaxis. This combination is supported by Yang et al in a 
recent cohort study, showing a lower risk for recurrent stroke than ASA and Plavix® single 
therapies [24]. Other studies have the last twenty years questioned the combination ASA + 
Plavix® and Diener et al showed a non-significant difference in prevention of cerebrovascular 
accidents when compared Plavix® single therapy with ASA + Plavix® combination therapy. 
In contrast, the risk of major hemorrhages was increased in this group. Another suggested 
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option is to add dipyridamole to stroke patients already on ASA, giving an additive prevention 
for new vascular events [25, 26]. The numbers of individuals in this study is not sufficient to 
make any longstanding conclusions, a more extensive retrospective study is needed to analyze 
antiplatelet post-stroke treatment at Palestine Medical Complex. The high appearance of 
treatment with Clexane® could be interpreted as a consequence of the short hospital stay and 
a lack of in-ward places.  
In this study Furosemid® (39%) were most common antihypertensive treatment, 
enalapril (28%) the second and atenolol/bisoprolol (22%) the third. When handling a patient 
with hypertension life style changes are of great importance for decreasing the risk of 
cardiovascular disease. Worldwide pharmacological treatment are used if the life style 
changes are insufficient for lowering the blood pressure. The first line treatment, 
recommended by the Swedish Council on Health Technology Assessment, consists of thiazide 
diuretics, angiotensin converting enzyme inhibitors, calcium antagonists, angiotensin receptor 
blockers and beta blockers. Furosemid® is not suggested as an antihypertensive treatment 
[27]. Sweileh et al described enalapril as the most common antihypertensive treatment at a 
hospital in northern Palestine [18]. This indicates that our result perhaps is a consequence of a 
low number of participants rather than an actual distribution of antihypertensive at PMC.  
The lack of rehabilitation/follow-up in elderly patients and in patients with severe 
stroke could be explained by lack of resources which leads to prioritizing younger people with 
moderate stroke symptoms. The negative prognosis of high age and severe stroke is well-
known, Appelros et al described a correlation between increased mortality risk within the first 
year after a first-ever stroke and the variables age and stroke severity [28]. The higher 
mortality in these groups may explain our results where older patients and patients with 
severe stroke received less rehabilitation. In our study we could not investigate the direct 
causes of the differences in rehabilitation prescription - a future more detailed study focusing 
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on the rehabilitation and different correlating variables is needed. The lack of resources at 
PMC is most likely affecting the health care of stroke patients and a raise in financial support 
is of greatest importance to increase the standard of treatment and rehabilitation.    
 
In the awareness part of this study only 75% could recognize ≥1 correct symptom, even lower 
(53%) among the patients in ages 15-39 years. Although when compared with a Korean 
awareness study structured in a similar way with open-ended questions, the total general 
knowledge was higher in our study population. In their study 56% could recognize ≥1 
symptom and 57% among 20-39 years could recognize ≥1 symptom. One interesting 
difference was in the age group ≥60 years: 49% in the Korean study compared to 91% in our 
study could recognize ≥1 symptoms [19]. Our study population were patients, compared to 
the randomized participants from public areas in the Korean study, and perhaps more 
educated in stroke symptoms.  
The correlation found between education level and increased knowledge of stroke risk 
factors/symptoms has been supported in previous awareness studies. Our results showed that 
elderly individuals were more likely to recognize correct symptoms. This is completely the 
opposite of the results in other studies, where the younger population were more likely to 
recognize risk factors and symptoms [19-22]. The variables smoking level and sex were not 
significantly associated with increased knowledge in this study. Accordingly, our hypothesis 
that education level is associated with a greater knowledge in stroke symptoms was 
strengthened. Our assumption that young age is associated with a greater knowledge was 
disproved in our study and in contrast a higher age turned out to be correlated with knowledge 
of stroke symptoms. Our findings need to be followed up by an awareness study 
representative for the whole population to address the areas for public information (awareness 
campaigns). 
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Limitations 
As mentioned in the method the aim of the observation study was to include every patient 
with diagnosed stroke passing by the ER at PMC. An unknown number of stroke patients 
were discharged directly from the ER, after CT scan. According to the journal system 45 
patients were diagnosed with cerebral infarction during the study time period. Though, the use 
of diagnosis codes (ICD) at the ER was inconsistent, therefore it was not possible to get the 
exact number of drop-outs. The questionnaire was distributed to in-ward, non-stroke patients 
and not completely representative for the Palestinian population. A more varied population 
could be a better way to investigate awareness. In this study we had limited access to 
interpreters and therefore we chose to investigate the awareness among in-ward patients. The 
questionnaire could be extended with more variables and questions e.g. about the source of 
stroke knowledge. To prevent a high drop-out rate we used a simple structure in the 
questionnaire which could contribute to a simplified explanation regarding awareness. 
Probably we have a translation bias in the questionnaire part of this study, e.g. the definitions 
of emotional stress, depression and anxiety are overlapping and could easily be confounding.  
 
 
Conclusions 
Patients with severe stroke and high age were less frequently receiving rehabilitation and 
follow-up in our stroke population at PMC. We found that some generally unproven treatment 
combinations were common among stroke patients. Both the disparity in rehabilitation and the 
unusual treatment policies could be ruled out in future studies with a larger patient material 
and with more narrowed research questions. This could possibly contribute to guidelines for 
treatment and rehabilitation at Palestine Medical Complex. A raise of financial support to 
stroke units is suggested to increase the standard of cerebrovascular health care.    
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The awareness study showed a lack of general knowledge concerning stroke 
symptoms. Patients with university studies were more likely to recognize more than two risk 
factors and elderly individuals were more likely to recognize stroke symptoms. Public 
education is needed to increase the awareness of common risk factors and the knowledge of 
stroke symptoms. The main focus should be to reach, in particular, young and low-educated 
people. To address the most important areas of improvement we suggest a more 
comprehensive awareness study with a more varied study population. 
 
 
Populärvetenskaplig sammanfattning 
Denna studie genomfördes våren 2014 på Palestine Medical Complex (PMC) i Ramallah, 
Västbanken, det ockuperade palestinska territoriet (oPt). Studien var uppdelad i två delar: en 
del där vi undersökte strokepatienter och en annan del där vi frågade patienter, som inte haft 
stroke, om deras kunskaper angående symtom och riskfaktorer för stroke.  
Vi fann att strokepatienterna i ovanligt hög utsträckning behandlades med två olika 
behandlingsprinciper som har varit ifrågasatta och inte finns med i dagens 
behandlingsriktlinjer, acetylsalicylsyra + Plavix® för att förebygga nya blodproppar och 
Furosemid® för att sänka blodtrycket. En viktig del av dagens strokebehandling är 
rehabilitering för att minska risken för bestående men. De äldre patienterna och patienterna 
med allvarligare stroke i vår studie fick sällan rehabilitering och uppföljning jämfört med de 
yngre patienterna och patienterna med lindrigare stroke. För att komma fram till dessa resultat 
undersöktes 29 strokepatienter och vi samlade in material från dessa patienter angående 
riskfaktorer, behandling och uppföljning. Denna studie behöver följas upp av en mer 
omfattande studie där det är möjligt att undersöka samtliga strokepatienter på PMC. 
Eventuellt skulle detta kunna bidra med underlag till framtida riktlinjer angående behandling 
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och rehabilitering på PMC. 
I den andra delen använde vi oss av ett frågeformulär för att undersöka kunskapsläget 
om symtom och riskfaktorer i stroke bland icke-strokepatienter på PMC. Våra resultat visade 
att framför allt kunskaperna om strokesymtom var begränsade, endast 75% i vår studie kunde 
nämna ett eller flera symtom. Vi såg också ett samband mellan universitetsstudier och ökad 
kunskap om riskfaktorer samt ett samband mellan hög ålder och ökad kunskap om symtom. 
Vårt material samlades in från patienter på en avdelning och därför finns det ett behov av en 
liknande studie på en population som är mer representativ för hela befolkningen. Denna skulle 
i sin tur kunna undersöka brister i kunskapsområden som kan förebyggas genom en allmän 
informationskampanj om stroke. Att öka kunskapen om stroke i befolkningen är viktigt för att 
förbättra överlevnaden i stroke genom att snabbare komma in till sjukhus för akut behandling. 
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Appendix 1 – Questionnaire  
 
Questionnaire – Stroke risk factors and symptoms 
When there are several alternatives - please circle the alternative which matches you best. 
 
1. How old are you?  __________________ 
2. What is your gender?   Male  Female 
3. What is your nationality?  __________________ 
4. What is your highest completed education level?  
No education Obligatory school  Secondary school  University 
5. Do you smoke?  
Never smoking   Smoked, but stopped  Smoking 
6. Do you know any risk factors for stroke? Please name 4 factors or less 
below, the most important factor first and the least important factor last. 
1. __________________________________________________ 
2. __________________________________________________ 
3. __________________________________________________ 
4. __________________________________________________ 
7. Do you know any typical stroke symptoms? Please name 4 signs or less 
below. 
1. __________________________________________________ 
2. __________________________________________________ 
3. __________________________________________________ 
4. __________________________________________________ 
Thank you for participating! 
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Appendix 2 – Protocol 
Check-list for questions stroke patients  Identification no: ____________________  
Time to hospital:   Age:   
 
Gender:    Heredity CVA: 
 
Previous diagnoses 
Previous TIA/stroke:   Previous CAD: 
 
Atrial fibrillation:   Smoking:  
 
Diabetes:    Hypertension: 
 
BMI:    Hyperlipidaemia:  
 
Treatment: 
 
Status 
Symptoms day 1: 
 
NIHSS:    Orientation:  
   
Nystagmus/eye movements:   Facial motoric funct.:  
 
Motoric funct.:    Finger-nose:   
 
Heel-knee:    Sensibility:  
   
Verbal communication:   Dysarthria/dysphasia:  
 
Neglect: 
 
 
Hearing:    Romberg:  
   
Uvula deviation:   Visual field, pupillary react.: 
   
Diadochokinesia:   Babinski: 
 
Finger play:    Reflexes:   
 
Heart ausc:    BP Day 1:        BP Day 2: 
 
P-glucose:     
 
Assessment and follow-ups 
Diagnosis:    Diagnostics: 
 
Treatment:     Active treatment start: 
 
Rehabilitation:    Follow-up: 
 
Examination day:    Discharge day:  
 
